The role of osteopontin in the progression of solid organ tumour.

Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D, Ma D. · 2018

Read The role of osteopontin in the progression of solid organ tumour. by Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D, Ma D. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5834520.txt.

Introduction

Zhao and co-authors review osteopontin, a bone protein that also helps solid tumors grow and spread. Their review appeared in Cell Death & Disease. Osteopontin talks to cells through integrins and CD44. Those signals steer growth, movement, and blood vessel building.

The survey crosses a dozen cancer types, from brain to ovary. In each, extra osteopontin tracks with faster growth and wider spread. The protein helps tumors anchor, migrate, and seed new sites. It also feeds the vessels that supply them. The authors close on therapy, asking how best to block a protein with so many jobs.

Catalog record

CREATORZhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D, Ma D.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5834520

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The role of osteopontin in the progression of solid organ tumour By Hailin Zhao, Qian Chen, Azeem Alam, Jiang Cui, Ka Chun Suen, Aurelie Pac Soo, Shiori Eguchi, Jianteng Gu, Daqing Ma Published in: Cell Death & Disease DOI: 10.1038/s41419-018-0391-6 ABSTRACT Osteopontin (OPN) is a bone sialoprotein involved in osteoclast attachment to mineralised bone matrix, as well as being a bone matrix protein, OPN is also a versatile protein that acts on various receptors which are associated with different signalling pathways implicated in cancer. OPN mediates various biological events involving the immune system and the vascular system; the protein plays a role in processes such as immune response, cell adhesion and migration, and tumorigenesis. This review discusses the potential role of OPN in tumour cell proliferation, angiogenesis and metastasis, as well as the molecular mechanisms involved in these processes in different cancers, including brain, lung, kidney, liver, bladder, breast, oesophageal, gastric, colon, pancreatic, prostate and ovarian cancers. The understanding of OPN’s role in tumour development and progression could potentially influence cancer therapy and contribute to the development of novel anti-tumour treatments. FACTS Osteopontin (OPN) is a versatile protein that acts on various receptors which are associated with different signalling pathways implicated in cancer.OPN mediates critical processes for cancer progression such as immune response, cell adhesion and migration, and tumorigenesis. OPEN QUESTIONS What are the precise molecular mechanisms of osteopontin in tumour progression?How is osteopontin related to the diagnosis and prognosis of cancer?Which therapeutic strategy targeting osteopontin would be the most effective in treating cancer in the clinical settings? INTRODUCTION Malignant cancers are described as uncontrolled growths which overcome replicative senescence, resulting in metastatic disease1. There are many factors that have essential functions in the regulation of the survival, proliferation, adhesion and migration of neoplastic cells, such as various growth factors and cytokines1. Recently there has been ongoing research regarding the role of osteopontin in tumour progression. This review provides an insight into the potential role that osteopontin may play in tumour cell proliferation, angiogenesis and metastasis and the molecular mechanisms underlying tumour progression in various organs. Biology of osteopontin Molecular pathway of osteopontin Not only is Osteopontin (OPN) a major non-collagenous bone matrix protein (which gave it its name), it also plays a role in other systems. For example, as an intrinsic component of the immune system, OPN controls cytokine production and regulates cell trafficking 2. OPN is an acidic arginine-glycine-aspartate-containing adhesive glycoprotein with a molecular mass of approximately 44 kDa (Fig. 1)2. The central section of the molecule consists of sequences that interact with seven integrins, such as αvβ3 and β5, as well as a sequence of β1-consisting integrins and a cryptic α9β1 region that is only functional after protease cleavage, thus suggesting a specific role for OPN fragments3. Not only does OPN communicate with cells via integrins, but also via CD44, which involves an intracellular interaction4. OPN has a conserved region that separates both the integrin and CD44 binding domains, which possess distinct signalling functions5. Different isoforms of CD44 are produced by alternate splicing of the pre-mRNA and have been found in different cancer cells6. The presence of these isoforms in different cancers suggests that they can be used as a marker for cancer progression and patient survival.Fig. 1The OPN gene, protein, signalling pathway and function in normal tissues.a The schematic representation of the location of OPN on human chromosome 4.OPN is at location 4q22.1. Genes encompassed within a 600 kb region on chromosome 4 encodes several noncollagenous bone and dentin proteins including OPN, bone sialoprotein(BSP), dentin matrix protein I (DMPI) and dentin sialophosphoportin (DSPP). All of them are classified as small intergrin-binding ligand N-linked glycoprotein (SIBLING) family proteins. b The signalling pathway of osteopontin. Osteopontin binds integrin α4β1 which causes degradation of phospharylated inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ). Inhibitor of nuclear transcription factor kappa-B (IκBα) and nuclear transcription factor kappa-B (NF-κB; p50 and p65) are both freed following this process. IκBα is degraded by the ubiquitination pathway, while NF-κB enters the cell nucleus where it is phosphorylated and it enhances the expression of pro-survival genes. Moreover, upon binding of osteopontin to integrin α4β1, phosphorylated IKKβ causes inactivation of Forkhead box O3 (FOXO3A). Active FOXO3A is important in decreasing the expression of anti-survival genes such as BIM, BAK and BAX which cause caspase activation and cell apoptosis via mitochondrion and release of cytochrome c. Activation of OPN mediate a diverse range of cellular function, including cell survival/ proliferation, cell-cycle progression, cell migration, endothelial mesenchymal transition, T cell activation, cytokine production, fibrosis, angiogenesis and bone calcification and mineralisation2 OPN is mainly synthesised by osteoblasts, osteocytes and other hematopoietic cells7. In addition, OPN is also secreted by neutrophils, dendritic cells, NK cells, T cells and B cells8. The structure of OPN is relatively simple, with about 300 amino acids composing a single chain polypeptide and expressed as a 33-KDa nascent protein8. OPN is actively involved in many physiological functions. It is an important factor in bone remodelling, anchoring osteoclasts to the mineral matrix of bones9. In addition, OPN regulates both the innate and adaptive immune systems. Functioning in a similar manner to T cell helper 1 cytokines, OPN promotes a cell-mediated immune response10. OPN contains an integrin –binding RGD sequence that interacts with CD44v 6/7, which is a cell surface glycoprotein involved in cell-cell interactions. OPN can also activate intracellular pathways to regulate gene expression within the immune system11. The important role of OPN in cell differentiation has been thoroughly investigated and it has been shown to suppress adipogenic differentiation and promote osteogenic differentiation in mesenchymal stem cells by interacting with integrin αvβ112. In addition, OPN regulates cytokine production 2. In summary, OPN is a protein with a diverse array of functions, ranging from the regulation of bone mineralisation, to recruiting macrophages and facilitating cell adhesion and migration. General role of osteopontin in cancer progression In addition to its role in mediating normal physiological responses, the role of OPN signalling pathways in cancer progression is becoming increasingly recognised (Fig. 2)13 and it has been shown to be involved in multi-steps of tumour metastasis (Fig. 3).Fig. 2The signalling pathway of osteopontin in tumour progression.Osteopontin (OPN) can interact with several integrins in Arg-Gly-Asp (RGD) dependent and RGD independent manners13. OPN can also interact with the CD44 family of receptors. Upon binding of receptors, OPN can induce cellular reactions include: survival, motility and tumour progression, MMP localisation and complement inhibition. By interacting with CD44 family of receptors, OPN can activate the cell anti-apoptotic signals in tumour cells through hospholipase C-γ(PLCγ–protein kinase C (PKC)–phosphatidylinositol 3-kinase (PI3K)–Akt pathway. Phosphatase and tensin homologue (PTEN) could inhibit Akt phosphorylation. Upon binding to αv β3, OPN activates AP1 through nuclear factor-inducing kinase (NIK)–ERK (extracellular signal-related kinase) and MEKK1 (mitogen-activated protein kinase kinase kinase1)–JNK1 (c-Jun N-terminal kinase 1) signalling pathways. AP1 promotes cancer cells motility and tumour progression. In addition, transactivation of epidermal growth factor receptor (EGFR) by OPN promotes phosphorylation of ERK which ultimately leads to activation of AP1. Activation of both MMP and HIF-1 pathways leads to enhanced tumour cell survival, proliferation, invasion and angiogenesis2Fig. 3The role of osteopontin in multi-steps of cancer cell metastasis.The OPN overexpression induces multi-steps of cancer cell metastasis

Read the complete text